Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02812160 · ClinicalTrials.gov registry record · NA
Spatz Adjustable Balloon for Obesity (SABO)
A NA study of Obesity, sponsored by Spatz FGIA.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
- 7
- Study locations
NCT02812160: Completed NA study of Obesity, sponsored by Spatz FGIA.
NCT02812160 is a NA study of Obesity that has completed, run by Spatz FGIA. The registered enrollment target is 288 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02812160, a NA study of Obesity, has completed, sponsored by Spatz FGIA.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.
Conditions Studied
Interventions
- DEVICE Spatz3 Adjustable Balloon
Study Locations (7)
Illinois
- University of Chicago - Chicago
Louisiana
- Surgical Specialists of Louisiana - Metairie
Maryland
- Endoscopic MicroSurgery Associates - Towson
Massachusetts
- Brigham and Womans Hospital - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- NY Manhattan VA Hospital - New York
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2016-09-12 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02812160
The ClinicalTrials.gov registry entry for NCT02812160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The listed sponsor is Spatz FGIA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Spatz3 Adjustable Balloon is the first listed.
NCT02812160 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Illinois, Louisiana, Maryland.
Frequently Asked Questions
What is clinical trial NCT02812160 about?
NCT02812160 is a clinical study titled "Spatz Adjustable Balloon for Obesity (SABO)". The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.
What is the current status of trial NCT02812160?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2016-09-12. Estimated completion is 2019-01.
What conditions does trial NCT02812160 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT02812160?
The interventions under investigation include: Spatz3 Adjustable Balloon (DEVICE).
Who is sponsoring clinical trial NCT02812160?
This trial is sponsored by Spatz FGIA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02812160 being conducted?
This trial has 7 study locations across Illinois, Louisiana, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.